Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 160

1.

Serotonin receptor antagonists for highly emetogenic chemotherapy in adults.

Billio A, Morello E, Clarke MJ.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006272. doi: 10.1002/14651858.CD006272.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;12:CD006272.

PMID:
20091591
[PubMed - indexed for MEDLINE]
2.

Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial.

Saito M, Aogi K, Sekine I, Yoshizawa H, Yanagita Y, Sakai H, Inoue K, Kitagawa C, Ogura T, Mitsuhashi S.

Lancet Oncol. 2009 Feb;10(2):115-24. doi: 10.1016/S1470-2045(08)70313-9. Epub 2009 Jan 8. Erratum in: Lancet Oncol. 2010 Mar;11(3)226.

PMID:
19135415
[PubMed - indexed for MEDLINE]
3.

WITHDRAWN: Serotonin receptor antagonists for highly emetogenic chemotherapy in adults.

Billio A, Morello E, Clarke MJ.

Cochrane Database Syst Rev. 2013 Dec 9;12:CD006272. doi: 10.1002/14651858.CD006272.pub3. Review. No abstract available.

PMID:
24323437
[PubMed - indexed for MEDLINE]
4.

Palonosetron: an evidence-based choice in prevention of nausea and vomiting induced by moderately emetogenic chemotherapy.

Celio L, Agustoni F, Testa I, Dotti K, de Braud F.

Tumori. 2012 May-Jun;98(3):279-86. doi: 10.1700/1125.12393. Review.

PMID:
22825501
[PubMed - indexed for MEDLINE]
5.

Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.

Rubenstein EB.

Clin Adv Hematol Oncol. 2004 May;2(5):284-9. Review.

PMID:
16163194
[PubMed - indexed for MEDLINE]
6.

Clinical update on palonosetron in the management of chemotherapy-induced nausea and vomiting.

Celio L, Denaro A, Canova S, Gevorgyan A, Bajetta E.

Tumori. 2008 Jul-Aug;94(4):447-52. Review.

PMID:
18822676
[PubMed - indexed for MEDLINE]
7.

A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy.

Aapro MS, Grunberg SM, Manikhas GM, Olivares G, Suarez T, Tjulandin SA, Bertoli LF, Yunus F, Morrica B, Lordick F, Macciocchi A.

Ann Oncol. 2006 Sep;17(9):1441-9. Epub 2006 Jun 9.

PMID:
16766588
[PubMed - indexed for MEDLINE]
Free Article
8.

Efficacy and safety of palonosetron for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis of randomized controlled trials.

Popovic M, Warr DG, Deangelis C, Tsao M, Chan KK, Poon M, Yip C, Pulenzas N, Lam H, Zhang L, Chow E.

Support Care Cancer. 2014 Jun;22(6):1685-97. doi: 10.1007/s00520-014-2175-6. Epub 2014 Mar 4. Review.

PMID:
24590374
[PubMed - indexed for MEDLINE]
9.

Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy.

Chiou TJ, Tzeng WF, Wang WS, Yen CC, Fan FS, Liu JH, Chen PM.

Zhonghua Yi Xue Za Zhi (Taipei). 2000 Oct;63(10):729-36.

PMID:
11076429
[PubMed - indexed for MEDLINE]
10.

Comparative efficacy and safety of palonosetron with the first 5-HT3 receptor antagonists for the chemotherapy-induced nausea and vomiting: a meta-analysis.

Jin Y, Sun W, Gu D, Yang J, Xu Z, Chen J.

Eur J Cancer Care (Engl). 2013 Jan;22(1):41-50. doi: 10.1111/j.1365-2354.2012.01353.x. Epub 2012 Apr 22. Review.

PMID:
22519361
[PubMed - indexed for MEDLINE]
11.

Palonosetron (Aloxi) and dexamethasone for the prevention of acute and delayed nausea and vomiting in patients receiving multiple-day chemotherapy.

Musso M, Scalone R, Bonanno V, Crescimanno A, Polizzi V, Porretto F, Bianchini C, Perrone T.

Support Care Cancer. 2009 Feb;17(2):205-9. doi: 10.1007/s00520-008-0510-5. Epub 2008 Oct 7.

PMID:
18839220
[PubMed - indexed for MEDLINE]
12.

Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron.

Gralla R, Lichinitser M, Van Der Vegt S, Sleeboom H, Mezger J, Peschel C, Tonini G, Labianca R, Macciocchi A, Aapro M.

Ann Oncol. 2003 Oct;14(10):1570-7.

PMID:
14504060
[PubMed - indexed for MEDLINE]
Free Article
13.

Granisetron. An update of its therapeutic use in nausea and vomiting induced by antineoplastic therapy.

Yarker YE, McTavish D.

Drugs. 1994 Nov;48(5):761-93. Review.

PMID:
7530631
[PubMed - indexed for MEDLINE]
14.

Palonosetron: a second-generation 5-hydroxytryptamine receptor antagonist.

Navari RM.

Future Oncol. 2006 Oct;2(5):591-602. Review.

PMID:
17026451
[PubMed - indexed for MEDLINE]
15.

The antiemetic 5-HT3 receptor antagonist Palonosetron inhibits substance P-mediated responses in vitro and in vivo.

Rojas C, Li Y, Zhang J, Stathis M, Alt J, Thomas AG, Cantoreggi S, Sebastiani S, Pietra C, Slusher BS.

J Pharmacol Exp Ther. 2010 Nov;335(2):362-8. doi: 10.1124/jpet.110.166181. Epub 2010 Aug 19.

PMID:
20724484
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

[Recent improvements in antiemetic therapy].

Roila F, Palladino MA, Ciccarese G, Basurto C.

Tumori. 1997;83(2 Suppl):S3-14. Review. Italian.

PMID:
9235727
[PubMed - indexed for MEDLINE]
17.

Palonosetron plus dexamethasone in highly emetogenic chemotherapy: pooled data from two Phase III trials.

Celio L, Agustoni F, Ricchini F, Dotti K, Niger M, Braud FD.

Future Oncol. 2013 Oct;9(10):1451-8. doi: 10.2217/fon.13.153.

PMID:
24106896
[PubMed - indexed for MEDLINE]
Free Article
18.

Is ondansetron more effective than granisetron for chemotherapy-induced nausea and vomiting? A review of comparative trials.

Vrabel M.

Clin J Oncol Nurs. 2007 Dec;11(6):809-13. Review.

PMID:
18063539
[PubMed - indexed for MEDLINE]
19.

A systematic review and meta-analysis of intravenous palonosetron in the prevention of chemotherapy-induced nausea and vomiting in adults.

Likun Z, Xiang J, Yi B, Xin D, Tao ZL.

Oncologist. 2011;16(2):207-16. doi: 10.1634/theoncologist.2010-0198. Epub 2011 Jan 31. Review.

PMID:
21282670
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Palonosetron: a unique 5-HT3-receptor antagonist for the prevention of chemotherapy-induced emesis.

Grunberg SM, Koeller JM.

Expert Opin Pharmacother. 2003 Dec;4(12):2297-303. Review.

PMID:
14640928
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk